The Stock Scoop ⚡ The royal hangover Read our latest newsletter here 👉 newsletter.thestocknetwork.c… Global stock markets spent this week doing their best impression of a long weekend gone wrong - a big Friday blowout, a rough Monday and a Tuesday spent paying for it. It all started when the Nasdaq posted its biggest fall in over a year. By Monday, the panic had crossed the Pacific. The ASX slept through all of that thanks to Monday’s King's Birthday public holiday - then woke up to find the bill on the doormat. The ASX 200 dropped sharply on Tuesday stabilising throughout the week. Just when the week needed a grand finale today confirmation came through @SpaceX will become a public company in the biggest IPO of all time. The rocket has officially launched; we’ll need to wait and see if the stock does too. This edition features: @EBRSystemsInc (ASX:EBR) @Alpha_HPA (ASX:A4N) Pengana Private Equity Trust (ASX:PE1) @KincoraCopper (ASX & TSXV:KCC) @TennantMinerals (ASX:TMS) @Axel_REE (ASX:AXL) @49Metals (ASX:49M) @MetroMining (ASX:MMI) @AlligatorEnergy (ASX:AGE) Boresight (ASX:BST) @Li_FTPower (ASX:LFT) SkinKandy (ASX:SK1) 👇 Subscribe for free stock news, interviews & investor education newsletter.thestocknetwork.c…

Environmental Clean Technologies Limited (ASX:ECT) has commenced a strategic commercialisation review of its proprietary COLDry® technology, assessing a range of pathways to bring it to market and maximise shareholder value. COLDry is a low-temperature lignite processing technology capable of producing value-added products for applications including agriculture. 🌱 Commercialisation review underway: Environmental Clean Technologies has engaged RSM Corporate Australia to provide an independent assessment of potential commercialisation pathways for COLDry, including licensing opportunities, partnerships, alternative applications and commercial structures. 🏭 Expanding market opportunities: The review will examine both Environmental Clean Technologies’ existing commercial relationships and broader opportunities for COLDry. 🤝 Strategic partnerships under review: Environmental Clean Technologies will also assess its ongoing relationship with Zero Quest, which is developing fertiliser products incorporating COLDry technology, as part of the broader evaluation of future commercial opportunities. “ECT has spent more than two decades developing COLDry and we believe the technology has reached an important stage in its commercial development. This review is intended to ensure the Board considers the full range of opportunities available to maximise value from the technology.” - Environmental Clean Technologies Executive Chairman Faldi Ismail ASX announcement ⚡ cdn-api.markitdigital.com/ap…

Neometals (ASX:NMT) has unveiled positive Phase 2 metallurgical testwork results from the Ironclad Gold Deposit at its 100%-owned Barrambie Gold Project in Western Australia. 🪓 Phase 2 metallurgical testwork completed on seven composite samples from the Ironclad Gold Deposit. 🛘 Delivered gravity gold recoveries up to 35.1% and overall gold recoveries up to 97.9%, averaging 91%. ⚒️ Results confirmed the ore is amenable to conventional gravity concentration and cyanide leach processing. 🔎 Outcomes reinforced previous metallurgical testwork results and exceeded the recovery assumptions used in the Scoping Study. “These results are in line with previous metallurgical testwork and confirm that Ironclad ores are amenable to processing via a conventional gravity and leach flowsheet." Chris Reed, Neometals Managing Director ASX announcement ⚡ cdn-api.markitdigital.com/ap… @neometalsltd $NMT

The biggest IPO in history starts trading on Friday, SpaceX, priced at $135 a share with a valuation of about USD $1.75 trillion, making it one of the ten most valuable companies on in the world. Last year SpaceX made $18.7 billion in revenue but lost almost $5 billion. It’s high-speed internet group Starlink prints money, but the AI side of the business is burning billions each quarter. Morningstar says SpaceX is worth $780 billion, which is almost $1 trillion lower than where the IPO pricing landed. When record demand meets a record price, who is right — the crowd, or the calculators? Space Exploration Technologies Corp (NASDAQ:SPCX) will list on the Nasdaq with a ticker code of SPCX. #SpaceX #IPO #ElonMusk #stocks #tech @SpaceX $SPCX

Australia’s media landscape is changing with deals around every corner. This week Vinyl Group (ASX:VNL) has announced two acquisitions, starting the week with buying Pedestrian then following up with Time Out. The Pedestrian acquisition is being acquired from Nine Digital for a nominal consideration. Vinyl says Pedestrian is one of Australia’s most recognised original youth media brands and Time Out one of the world’s most iconic culture brands. This comes after Vinyl bought Val Morgan Digital, the local publisher of Buzzfeed, Ladbible and PopSugar, for $10.5m in cash and shares in March 2026. Vinyl believes the future of media is not just reaching big audiences but integrating brands and cultural moments. #media #finance #money #stocks #future @vnlasx $VNL

Pengana Private Equity Trust (ASX: PE1) has delivered its May 2026 portfolio update, highlighting positive monthly performance and strengthening its exposure to growth opportunities across private markets, including enterprise AI, business services, and specialist healthcare. The portfolio remains well diversified across private equity investments, with significant exposure to North America and key sectors including industrials, information technology, and financial services. During the month, PE1 completed two new investments and expanded existing high-conviction positions: 🔹 Increased exposure to Anthropic following its latest funding round, with ARR approaching US$50 billion. 🔹 Added a co-investment in Diverzify, the leading commercial flooring company in the US. 🔹 Invested in Lifeways, the UK's largest specialist supported living provider. 🔹 Received nearly 150% of funded capital back through the recapitalisation of Osaic while retaining a majority stake. 🔹 SpaceX, the largest position, has an upcoming potential IPO that is expected to be one of the largest in history. ASX announcement ⚡ cdn-api.markitdigital.com/ap… Pengana Investment Management Limited (Pengana) (ABN 69 063 081 612, AFSL 219 462) is the issuer of units in the Pengana Private Equity Trust (ARSN 630 923 643) (the Trust). General information only. Past performance is not a reliable indicator of future performance. Investments carry risk. Pengana Investment Management Limited (Pengana) (ABN 69 063 081 612, AFSL 219 462) is the issuer of units in the Pengana Private Equity Trust (ARSN 630 923 643) (the Trust). General information only. Past performance is not a reliable indicator of future performance. Investments carry risk. @Pengana_Capital #penganaprivateequitytrust $PE1

Imugene Limited (ASX:IMU) has received FDA Fast Track Designation for its allogeneic CAR T-cell therapy azer-cel in two blood cancer indications, relapsed or refractory Chronic Lymphocytic Leukaemia/Small Lymphocytic Lymphoma (CLL/SLL) and relapsed or refractory Marginal Zone Lymphoma (MZL). This development supports an expedited regulatory pathway for the company’s azer-cel therapy. 🩸FDA Fast Track Designation: azer-cel has been granted Fast Track Designation for both CLL/SLL and MZL, providing opportunities for more frequent FDA engagement, rolling review and potential eligibility for Accelerated Approval and Priority Review. 📊 Encouraging clinical results: Phase 1b data showed a 100% overall response rate (ORR) in the CAR T-naive CLL/SLL cohort, while updated MZL data demonstrated an 83% ORR, including four complete responses. ⚡ Off-the-shelf CAR T approach: azer-cel is a donor-derived, CD19-targeting CAR T-cell therapy designed to be available within days, potentially overcoming the manufacturing delays associated with traditional autologous CAR T treatments. “FDA Fast Track Designation for both CLL/SLL and MZL reflects the meaningful clinical activity we are seeing with azer-cel across multiple B-cell malignancies.” - Imugene Managing Director and CEO Leslie Chong ASX announcement ⚡ cdn-api.markitdigital.com/ap…

Chariot Resources (ASX:CC9) has significantly expanded its strategic position in the McDermitt Caldera after staking 573 additional claims at its Resurgent East Project in Nevada-Oregon. The move nearly doubles the Company’s landholding following a disciplined consolidation during the lithium downturn and strengthens its exposure alongside major neighbouring developments including Thacker Pass and Jindalee’s McDermitt Project. Chariot Resources Managing Director Shanthar Pathmanathan joins The Stock Network’s @LelSmits to discuss the expanded land position, the improving lithium market and the Company’s plans to unlock the potential of Resurgent. 🪓 Strategic expansion at Resurgent East 🛘 Positioned in a globally significant lithium district 🚀 Preparing for the next phase of growth Watch the full interview ⚡ youtu.be/7VYg6SGgEhs ASX announcement ⚡ cdn-api.markitdigital.com/ap… @ChariotCorp #CC9

Did you know some stocks market have an emergency off switch and on Monday, South Korea used theirs. The Kospi, Korea's main index, was in freefall. Down more than 8% within the first hour. So the exchange did something drastic and stopped everything. That's called a circuit breaker. Here's how Korea's works: if the index stays 8% or more below yesterday's close for a full minute trading halts for 20 minutes. No buying. No selling. Forced time-out. Falling prices trigger automatic selling, which triggers more falling. Machines panic faster than people. America has one too, the US market freezes if the S&P 500 falls 7%, but Australia doesn't. The ASX made a deliberate choice to have no master off switch. Instead, it pauses individual stocks that move too violently, and lets the market as a whole keep trading. The thinking: in a panic, investors need the exits open, not locked. #finance #stocks #ASX #investing #fintok

Exchange Traded Funds (ETFs) have become one of the fastest-growing investment vehicles globally, yet many investors are still unsure how they work, how to use them, and where to start. In this ETF Education Spotlight, presented in partnership with @WomeninETFs, The Stock Network’s @LelSmits is joined by Claudia Catalanotto, Sales Operations Manager at @vaneck_au, to break down the fundamentals of ETFs, explain why they’ve become so popular with investors, and provide practical education for those looking to better understand the product. 📘 ETF 101: What is an ETF and why are they growing so quickly? 🧩 Understanding the different types of ETFs 💡 What investors should know before buying an ETF 📋 Common misconceptions around ETFs 📈 Building a portfolio with ETFs Watch the full interview ⚡ youtu.be/rGW1FNFV8PU Please note: investing in ETFs carries risks. Not personal advice.

Boresight has listed on the ASX with the ticker code of BST. The company is a provider of Target Drones to western and allied militaries. These Drones emulate real world threats in a reliable and repeatable manner, and are sold at a price point that supports live-fire, testing, destructive evaluation and training without placing undue pressure on defence budgets. Considerable investment has already been made into the optimisation of the manufacture of the Target Drones. Boresight plans to use the proceeds of its IPO raise to fund expansion of its engineering and production teams, ramp up production in the United States, increase its additive manufacturing capacity and further vertically integrate operations. Website: boresightuas.com/ Media: The Stock Network, @LelSmits #boresight $BST

Alterity Therapeutics (ASX:ATH) has achieved alignment with the U.S. FDA on the design of its pivotal Phase 3 program for ATH434 in Multiple System Atrophy (MSA), advancing the drug candidate toward possible regulatory approval. ATH434 is a potential treatment for MSA, a rare and rapidly progressive neurodegenerative disease with no currently approved therapies. 🧠 FDA alignment achieved: The FDA agreed with key elements of the Phase 3 trial design, including the study population, treatment duration, primary endpoint and proposed 50mg twice-daily dosing regimen. 📊 Strong Phase 2 foundation: ATH434 previously demonstrated a 48% slowing of disease progression versus placebo on the Unified Multiple System Atrophy Rating Scale (UMSARS) Part I scale, with clinically and statistically significant efficacy at the selected dose. 🚀 Phase 3 preparations underway: Alterity Therapeutics remains on track to initiate Phase 3 trial activities by the end of 2026, with the program representing the final stage of clinical development before a potential FDA submission. “Achieving alignment with FDA at the End-of-Phase 2 meeting is a critical step for our Phase 3 program in MSA, providing the clarity we need to advance to this next stage.” - Dr David Stamler, Alterity Therapeutics CEO ASX announcement ⚡ announcements.asx.com.au/asx…

Impact Minerals (ASX:IPT) has advised that joint venture partner Kuniko Limited has secured a drill rig and will commence Phase 2 diamond drilling at the Commonwealth–Silica Hill Gold–Silver Project in New South Wales. 🚀 Phase 2 drilling set to begin in July 2026 following the successful completion of the Phase 1 exploration program. 🎯 Targeting a resource upgrade in H2 2026, with drilling focused on extending mineralisation at Silica Hill, Commonwealth Main Shaft, and Commonwealth South. 🛘 Phase 1 achieved a 100% drilling success rate, with all six drill holes intersecting mineralisation. ⛏️ Significant new discovery at Silica Hill, where drilling identified a mineralised zone approximately 100 metres beyond the existing footprint, remaining open in multiple directions. "We are pleased to see Kuniko accelerating exploration drilling at Commonwealth following the successful Phase 1 program, which identified significant step-outs to mineralisation, particularly at Silica Hill." Dr Michael Jones, Impact Minerals Managing Director ASX announcement ⚡ cdn-api.markitdigital.com/ap… @ImpactMinerals $IPT @KunikoLtd $KNI

Three major private equity firms are in a bidding war over oOh!media (ASX:OML) who makes the billboards you walk past every day. oOh!media runs more than 37,000 ad sites across Australia and New Zealand - the station screens, the shopping-centre posters, the bus-stop signs. First Pacific Equity Partners bid $1.40 a share, then I Squared Capital topped it with $1.45, and now a third has jumped in with the exact offer yet to be disclosed. So why the frenzy? Because in a world where we skip ads, block ads, and pay to avoid ads the billboard is the one ad you can't escape. No skip button. No ad-blocker. Ads that are just "there" while you wait for the train. That's rare now. And rare things can attract big money. #money #fintok #stocks #advertising #sales

Ionic Rare Earths (ASX:IXR) is positioning itself at the centre of the global push for secure and sustainable rare earth supply chains through its patented magnet recycling and refining technology. Through its wholly owned subsidiary Ionic Technologies, the company is developing a commercial-scale rare earth recycling facility in Belfast while expanding partnerships across the United States and Europe to establish a traceable, ex-China supply chain for critical materials. Ionic Rare Earths Managing Director Tim Harrison joins The Stock Network's @LelSmits to discuss the company's technology, recent U.S. defence-related agreements and the growing strategic importance of rare earth recycling. 🌏 Building a Western rare earth supply chain ⚙️ Commercialising Ionic Technologies 🇺🇸 U.S. defence and advanced manufacturing opportunity ♻️ Closing the loop through recycling 🚀 Growth outlook and global expansion Watch the full interview ⚡ youtu.be/sShMUmGuh4M @IONIC_RE $IXR

Chariot Resources (ASX:CC9) has expanded its lithium footprint in the McDermitt Caldera, with subsidiary FMS Lithium Corporation staking 573 additional mining claims at Resurgent East. 🪓 Pro forma claim position expected to increase from 597 to approximately 1,170 claims, subject to regulatory processing ⚒️ Expanded tenure strengthens Chariot's position in the eastern McDermitt Caldera 🔋 Project is located adjacent to major lithium developments, including Lithium Americas' Thacker Pass project and Jindalee Lithium's McDermitt project 🛘 Expansion follows improving lithium market conditions and increasing third-party interest in the region ASX announcement ⚡ cdn-api.markitdigital.com/ap… @ChariotCorp #CC9

#HREE Chairman Ivan joined @TheStockNet to present Harena Key points included U.S. DFC engagement, progress towards mining licence, and path to first concentrate from Ampasindava within 24 months. Ivan also noted HREE is the only ionic clay rare earth company listed on the LSE. harenaresources.com/activity…

Impact Minerals (ASX: IPT) has appointed Jim McKerlie as Independent Non-Executive Chair as the company progresses its Lake Hope High Purity Alumina (HPA) Project from pre-feasibility into the definitive feasibility study stage. 🔎 Jim McKerlie is an experienced board director, international executive, corporate adviser and strategy consultant 🪓 Focused on supporting the transition from explorer to producer 🚀 Strengthening capital markets engagement and governance frameworks "Impact Minerals is at a well-defined inflection point, and I joined because the fundamentals are compelling. The Lake Hope HPA Project has completed its Pre-Feasibility Study and is advancing to a Definitive Feasibility Study." Mr Jim McKerlie, Impact Minerals Independent Non-Executive Chair “We are very pleased to welcome Jim as Chair. His experience in capital markets, strategy execution, and ASX governance is precisely what Impact needs as we move from developer to producer." Dr Michael Jones, Impact Minerals Managing Director ASX announcement ⚡ cdn-api.markitdigital.com/ap… @ImpactMinerals $IPT

Island Pharmaceuticals (ASX:ILA) has commenced Good Manufacturing Practice (GMP) manufacturing of Galidesivir, advancing the antiviral candidate toward pivotal studies under the US FDA’s Animal Rule pathway and supporting broader biodefence and outbreak response opportunities. 🧪 Manufacturing milestone: GMP manufacturing is underway with PI Health Sciences, providing the clinical-grade Galidesivir required for planned pivotal efficacy studies and future regulatory submissions. 🛡️ Biodefence opportunity: The program strengthens Island Pharmaceuticals’ ability to pursue biodefence, pandemic preparedness and emerging infectious disease opportunities, including potential applications against Marburg and Ebola virus outbreaks. 📈 Commercialisation pathway: The manufacturing campaign establishes the quality, analytical and production systems needed to support future approval processes, government procurement opportunities and late-stage development. “The commencement of GMP manufacturing is a significant milestone and represents another important step in the commercialisation pathway for Galidesivir.” - Dr David Foster, Island Pharmaceuticals CEO and Managing Director ASX announcement ⚡ announcements.asx.com.au/asx…

The Stock Scoop ⚡ Mega IPOs are coming Read our latest newsletter here 👉newsletter.thestocknetwork.c… War, inflation, interest rates, and now the age of the mega IPO. Markets have had plenty to digest in 2026, and we're breaking down the biggest developments shaping the investment landscape. @SpaceX has launched its IPO roadshow targeting a record-breaking valuation, while @AnthropicAI has filed to go public at a near-trillion-dollar valuation, leapfrogging @OpenAI in the process. The world's most valuable private companies are racing toward the public markets, raising big questions about valuation, AI optimism, and what it all means for investors. Closer to home, Australia's largest companies are positioning themselves to benefit from the AI boom, while investors and super funds are already feeling the ripple effects. The challenge now isn't whether these giants will list, it's whether the valuations can live up to the hype. This edition features: @TIPGroup_Ltd (ASX:TIP) Acrux (ASX:ACR) Epiminder (ASX:EPI) @FEG_LTD (ASX:FEG) Nickel Industries (ASX:NIC) @ImpactMinerals (ASX:IPT) @GreenTechMetals (ASX:GRE) @tartanaminerals (ASX:TAT) @KaokoMetals (ASX:KAO) L1 Gold Fund (ASX:LGF) Solaris Australian Equity Income Plus (ASX:SET) 👇 Subscribe for free stock news, interviews & investor education newsletter.thestocknetwork.c…